Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Melanoma in a southeastern Hispanic population

L G Feun1, W A Raub, R C Duncan

  • 1Sylvester Comprehensive Cancer Center, University of Miami, FL 33136.

Cancer Detection and Prevention
|January 1, 1994
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Efficacy of high dose systemic versus combined (systemic and intratympanic) corticosteroid therapy in idiopathic sudden sensorineural hearing loss: A prospective randomized trial and risk factor analysis.

American journal of otolaryngology·2023
Same author

Stratification of alopecia areata reveals involvement of CD4 T cell populations and altered faecal microbiota.

Clinical and experimental immunology·2022
Same author

[COVID-19 and the central and peripheral nervous system].

Der Pathologe·2021
Same author

A clinical diagnostic algorithm for early onset cerebellar ataxia.

European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society·2019
Same author

Alopecia areata is characterized by dysregulation in systemic type 17 and type 2 cytokines, which may contribute to disease-associated psychological morbidity.

The British journal of dermatology·2019
Same author

Flow cytometric analysis of extracellular vesicle subsets in plasma: impact of swarm by particles of non-interest.

Journal of thrombosis and haemostasis : JTH·2018

Hispanic melanoma patients often present with localized disease, achieving an 87% 5-year survival. Survival rates for advanced melanoma were better in Hispanics compared to non-Hispanics.

Area of Science:

  • Oncology
  • Dermatology
  • Epidemiology

Background:

  • Malignant melanoma incidence and outcomes can vary significantly across different demographic groups.
  • Understanding the specific characteristics of melanoma in Hispanic populations is crucial for targeted public health initiatives and clinical care.

Purpose of the Study:

  • To describe the clinical presentation and survival outcomes of malignant melanoma in Hispanic patients.
  • To compare melanoma survival rates between Hispanic and non-Hispanic individuals, and between Hispanic males and females.

Main Methods:

  • A descriptive analysis of Tumor Registry data from Jackson Memorial Hospital (JMH) was conducted.
  • Fifty-four cases of melanoma in Hispanic patients were reviewed for lesion location, disease stage at presentation, and survival data.

Related Experiment Videos

Main Results:

  • Melanoma lesions in Hispanics most commonly occurred on the trunk, arm, shoulder, leg, and hip.
  • Seventy percent of Hispanic patients presented with local-stage disease, while 26% had regional or distant disease.
  • Five-year survival was 87% for local-stage disease. Combined regional and distant disease survival was better in Hispanics than non-Hispanics (p=0.01).
  • Hispanic patients over 50 had better survival than non-Hispanics in the same age group (p=0.05).
  • Hispanic females demonstrated a significantly better 5-year survival (86%) compared to Hispanic males (56%) (p=0.017).

Conclusions:

  • Hispanic patients with malignant melanoma often present with localized disease, associated with high survival rates.
  • Despite potential disparities, Hispanic individuals showed improved survival outcomes in advanced stages and specific age groups compared to non-Hispanics.
  • Significant survival differences exist between Hispanic males and females, highlighting the need for sex-specific considerations in melanoma care for this population.